![FDA/HESI Virtual Workshop: Research Roadmap Planning on Hazard and Risk Assessment of Nitrosamine Impuraties in Drugs May 31 at 9:00AM-5:00PM ET and June 1 at 8:30AM-3:45PM](https://public4.pagefreezer.com:443/content/FDA/30-04-2023T17:16/https://www.fda.gov/files/styles/medium_3/public/Workshop_FDAHESI_Nitrosamines_1600x900_230424_1434.png?itok=Z-DEzX4T)
Register for FDA/HESI workshop on nitrosamine risk research
April 28 - The 2-day workshop will discuss researching and assessing nitrosamine risk in drugs
April 28 - The 2-day workshop will discuss researching and assessing nitrosamine risk in drugs
April 26 - Webinar will cover fee types, collection and payment process, and more
April 21 - Resources include trainings, stakeholder engagement, and more
April 18 - Conversation showcases the importance of regulatory science research
April 17 - Webinar will highlight new features, best practices and more
April 13 - Updates made to help address opioid misuse, addiction, overdose and death
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.